Eurofins Strengthens Its Footprint in Food and Agroscience Testing in Japan with New Acquisitions
10 August 2017 - 3:30PM
Business Wire
Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA), the world leader in
food and agroscience testing services, announces the acquisitions
of Japan Analytical Chemistry Consultants Co. Ltd. (“JACC”) and
Ecopro Research K.K. (“Ecopro”). JACC is one of the largest
independent agroscience testing laboratories in Japan and Ecopro is
a leading food testing laboratory in Japan.
JACC is one of the largest Japanese independent GLP pesticide
residue laboratories for agrochemical-registration, with more than
40 years of chemical testing experience and know-how. JACC has the
accreditation from the Japanese Ministry of Agriculture, Forestry
and Fisheries (MAFF), and serves chemical and agrochemical clients
by offering pesticide analyses for river water, air and soil
samples as well as analyses for active agrochemical ingredients and
formulations. With accreditations from the Japanese Ministry of
Health, Labor and Welfare (MHLW) and MAFF, Ecopro provides food
testing services, including pesticide residue testing, nutrition
analyses, and microbiology testing. Ecopro focuses specifically on
tea samples and metabolome analysis for functional food. JACC and
Ecopro employ 40 and 30 staff, respectively.
The two acquisitions reinforce Eurofins’ leadership position in
the pesticide residue food market and provide Eurofins an entry in
the agroscience market in Japan. The acquisition of Ecopro
complements Eurofins’ existing local food-testing capabilities and
is strategically located in Shizuoka, the largest tea-producing
area in Japan.
Comment from Dr. Gilles Martin, Eurofins CEO: “The
acquisitions of JACC and Ecopro have a good strategic fit with
Eurofins’ existing food and agroscience testing businesses and will
help to expand our offerings in Japan. These acquisitions will
reinforce the Groups’ growing footprint in Asia Pacific, and are a
clear demonstration of our strong commitment in this geographical
region. We look forward to providing JACC and Ecopro access to the
full capabilities of the Eurofins network.”
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific through its subsidiaries (hereinafter sometimes
“Eurofins” or “the Group”) believes it is the world leader in food,
environment and pharmaceutical products testing and that it is also
one of the global independent market leaders in certain testing and
laboratory services for agroscience, genomics, discovery
pharmacology and for supporting clinical studies. In addition,
Eurofins is one of the key emerging players in specialty clinical
diagnostic testing in Europe and the USA. With over 30,000 staff in
375 laboratories across 41 countries, Eurofins offers a portfolio
of over 130,000 analytical methods for evaluating the safety,
identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170809005728/en/
Investor RelationsEurofins ScientificPhone: +32 2 766
1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Apr 2024 to May 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From May 2023 to May 2024